Vytlačiť
1.
- Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (doxetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer / W. P. Li ... [et al.]. Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Vol. 67, no. 6 (2020), s. 1409-1415 : ilustr., grafy, schéma, tab.
- C 720